Robert Kirby is Vice President of Regulatory Affairs.
He has significant domain expertise in the radiation oncology segment of the medical device space. He has held key roles for innovative radiation oncology companies in R&D, product management and U.S. and international business development.
Prior to joining TAE Life Sciences, Rob served as Vice President of R&D, marketing and strategy at Xoft, Inc., where he was also responsible for overseeing international expansion and operations. He led cross-functional teams that developed and launched products for cancer treatment, and supported multiple U.S. and international regulatory approvals. In his prior position at PerMedics, he led the team that developed, launched and obtained U.S. FDA clearance for proton radiation treatment planning software.
Rob holds a B.S. in Mechanical Engineering from University of California, Davis, and an MBA from the University of California, Riverside.